-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price was up 12.9% on Friday . The company traded as high as $9.15 and last traded at $8.49. Approximately 4,633,673 shares changed hands during trading, an increase of 37% from the average daily volume of 3,376,665 shares. The stock had previously closed at $7.52.
Mind Medicine (MindMed) Stock Up 12.9 %
The company has a fifty day moving average of $6.03 and a 200-day moving average of $7.22.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- California Resources Stock Could Be a Huge Long-Term Winner
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- 3 Small Caps With Big Return Potential
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
